FTSE All-Share
4.986,34
PKT
-9,01
PKT
-0,18
%
Werbung
Analysen zu FTSE All-Share-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 22.09.20 | Unilever buy | Jefferies & Company Inc. | |
| 22.09.20 | Unilever buy | Jefferies & Company Inc. | |
| 22.09.20 | BAT Outperform | RBC Capital Markets | |
| 22.09.20 | GSK Neutral | JP Morgan Chase & Co. | |
| 22.09.20 | Prudential Sector Perform | RBC Capital Markets | |
| 18.09.20 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 17.09.20 | BP Conviction Buy List | Goldman Sachs Group Inc. | |
| 17.09.20 | BP overweight | JP Morgan Chase & Co. | |
| 17.09.20 | BP Underperform | RBC Capital Markets | |
| 16.09.20 | Vodafone Group buy | Goldman Sachs Group Inc. | |
| 15.09.20 | BP buy | UBS AG | |
| 15.09.20 | Glencore Outperform | RBC Capital Markets | |
| 15.09.20 | BP Underperform | RBC Capital Markets | |
| 15.09.20 | Rio Tinto Equal weight | Barclays Capital | |
| 15.09.20 | Rio Tinto overweight | JP Morgan Chase & Co. | |
| 14.09.20 | Rio Tinto Neutral | UBS AG | |
| 14.09.20 | Shell (ex Royal Dutch Shell) Outperform | Credit Suisse Group | |
| 14.09.20 | BP Outperform | Credit Suisse Group | |
| 11.09.20 | Rio Tinto Neutral | JP Morgan Chase & Co. | |
| 11.09.20 | Rio Tinto buy | Jefferies & Company Inc. | |
| 11.09.20 | Rio Tinto Sector Perform | RBC Capital Markets | |
| 11.09.20 | BP overweight | Barclays Capital | |
| 11.09.20 | Lloyds Banking Group Sell | Goldman Sachs Group Inc. | |
| 10.09.20 | Rio Tinto Underperform | Credit Suisse Group | |
| 10.09.20 | BP buy | UBS AG | |
| 10.09.20 | London Stock Exchange (LSE) overweight | JP Morgan Chase & Co. | |
| 10.09.20 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 09.09.20 | Shell (ex Royal Dutch Shell) Outperform | RBC Capital Markets | |
| 09.09.20 | BP buy | Kepler Cheuvreux | |
| 09.09.20 | AstraZeneca Sell | UBS AG | |
| 09.09.20 | London Stock Exchange (LSE) Neutral | UBS AG | |
| 09.09.20 | AstraZeneca Hold | Jefferies & Company Inc. | |
| 09.09.20 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 09.09.20 | AstraZeneca overweight | Barclays Capital | |
| 08.09.20 | London Stock Exchange (LSE) Neutral | UBS AG | |
| 08.09.20 | Prudential overweight | Barclays Capital | |
| 08.09.20 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 08.09.20 | GSK Neutral | JP Morgan Chase & Co. | |
| 07.09.20 | Prudential Neutral | JP Morgan Chase & Co. | |
| 04.09.20 | Barclays buy | UBS AG |